S-TAI Biotechnology Co., Ltd. is engaged in the production, sub-production and sales of precisely sequencing peptide raw materials and products, covering health care products, maintenance products and existing products that have been added into functional products, and have remarkable performance in degeneration, metabolism, immunity and exercise.
From research and development, sequencing, production and confirmation, after 15 years of continuous improvement of technology and keeping pace with the times, a total of 80 groups of 5-peptides to 49-peptides have been produced, which are soluble in water, colorless and tasteless, and the source is large fish and algae that can be eaten in the ocean. During this period, we continued to discuss the application technology of protein with many well-known professors and industry experts, and also worked with the DCB Biotechnology Development Center to design animal and cell experimental models for the characteristics of each single peptide or combination peptide, so as to make the precise focus.
At the same time, he cooperated with Mr. Xie Chengzhang, the owner of Pu Shizhai, a wood-burning potter, to develop a peptide crystal kiln to add negative ion fendoxin to tea drinking, so that tea drinking can be integrated with the big health industry. In addition, it also combines with non-woven raw material manufacturers to add negative ions to the competitive advantage of raw materials for rehabilitation and disposable medical and sanitary materials.
At present, the ordered peptide types include mitochondrial type, molecular companion type, type I glue prototype, interferon type,TGFβ2R type, Nakp ion type, T cell CD4 type, TRAF3 type, STRF type, fatty acid decomposition type, new keratin cell repair type, and even modified peptides under development are available.
At present, under the demand of the precise focus market, the company has developed a variety of highly acclaimed health care products and maintenance products. It has also made good development in the fields of rehabilitation channels and medical and beauty, and has business dealings with brands and food factories. It is expected that the sequencing peptide can accurately open a new chapter in the health care market, contribute to the big health industry, and benefit the people.

Mail: stai@s-tai.com.tw

Interception and description of animal and cell experiments of DCB Biotechnology Development Center.
1、Mitochondria: Pretreatment of human adipose stem cells with H2O2 with peptide combination (simulating the state of cell aging) Preliminary evaluation of the anti-aging effect.
2、Mitochondria: Evaluation of the anti-fatigue effect of single peptide on mice.
3、Mitochondria: Efficacy evaluation of peptide combination 1 and 2 for MPTP-induced Parkinson's disease model mice.
4、Preliminary evaluation of the effect of mitochondria: peptide combination on chronic renal disease mode.
5、Evaluation of the osteoporosis model of type I collagen peptide on ovarian removal SD female rats.
6、Preliminary evaluation of the effect of peptide combination 1 and peptide combination 2 on rheumatoid arthritis rats.
7、Preliminary evaluation of the effect of single peptide and peptide combination on allergic rhinitis mouse model.
8、Preliminary evaluation of the effect of single peptide and peptide combination on dry ringworm (psoriasis) mouse mode (spray type).
9、Preliminary evaluation of the effect of single peptide and peptide combination on ischemic anemia mode.